Angiotensin-converting enzyme (ACE) inhibition in the secondary prevention of vascular disease: the Heart Outcomes Prevention Evaluation (HOPE) Trial and its substudies

Curr Atheroscler Rep. 2000 Sep;2(5):361-2. doi: 10.1007/s11883-000-0073-5.
No abstract available

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Clinical Trials as Topic
  • Coronary Artery Disease / drug therapy*
  • Coronary Artery Disease / prevention & control*
  • Humans


  • Angiotensin-Converting Enzyme Inhibitors